期刊文献+

精神疾病治疗进展(一):精神分裂症 被引量:40

Therapeutic Progress of Mental Diseases (First) : Schizophrenia
下载PDF
导出
摘要 精神分裂症发病率高,社会和家庭负担重。随着近半个世纪抗精神病药物在临床上的广泛应用,其治疗遵循早期、有效和维持的原则,临床预后日趋改善。该文从精神分裂症不同时期的临床特征,结合近年抗精神病药物的研究进展,阐述精神分裂症治疗药物的临床选择。 The high incidence of schizophrenia causes a greater burden on society and family. In the past of half century, with the widespread use of schizophrenic drugs,the prognosis of clinical schizophrenia has been substantially improved after following the principles of early, effective and maintenance therapy.In this overview,the clinical characteristics at different stages of disease progression with the recent advances in drug therapy of schizophrenia was combined, to introduce clinical selection of schizophrenic drugs.
出处 《医药导报》 CAS 2017年第10期1133-1137,共5页 Herald of Medicine
基金 浙江省高等学校中青年学科带头人项目(浙教办高科201360277) 浙江省卫生高层次人才医坛新秀(浙卫办2015第二期)
关键词 抗精神病药物 精神分裂症 药物治疗 Anti-schizophrenic drugs Schizophrenia Drug therapy
  • 相关文献

参考文献5

二级参考文献67

  • 1王继军,张明岛.精神分裂症的DUP[J].上海精神医学,2005,17(6):356-359. 被引量:19
  • 2施慎逊,周沫,陈海莹,张晋碚,梅其一,王传跃,李惠春,谭立文,谢世平,郑朝盾,曹长安,张仁川,陈振华,王志阳,王向群,罗剑锋.奎硫平两种剂量快速加量治疗精神分裂症急性期患者的对照研究[J].中华精神科杂志,2007,40(1):10-14. 被引量:13
  • 3高哲石.精神分裂症的药物治疗进展[J].世界临床药物,2007,28(4):204-208. 被引量:32
  • 4Mortimer AM, Joyce E, Balasubramaniam K, et al. Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia[J]. Hum Psychopharmacol, 2007, 22 (7) : 445-454.
  • 5Fleischhacker WW, McQuade RD, Marcus RN, et al. A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia [J]. Biol Psychiatry, 2009, 65 (6) : 510-517.
  • 6Boidi G, Ferro M. Rapid dose initiation of quetiapine for the treatment of acute schizophrenia and schizoaffective disorder: a randomised, multicentre, parallel-group, open study[J].Hum Psychopharmacol, 2007, 22 (5) : 299-306.
  • 7Canuso CM, Youssefa EA, Bossiea CA, et al.Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone[J]. Int Clin Psychopharmacol, 2008, 23 (4) :209-215.
  • 8Canuso CM, Bossie CA, Turkoz I, et al. Paliperidone extended-release for schizophrenia: effects on symptoms and functioning in acutely ill patients with negative symptoms [J]. Schizophr Res, 2009,113 (1): 56-64.
  • 9Marder SR, Kramer M, Ford L, et al. Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study [J]. Biol Psychiatry, 2007, 62 (12) : 1363-1370.
  • 10Davidson M, Emsley R, Kramer M, et al. Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo- controlled study [J]. Schizophr Res, 2007, 93 (1-3): 117-130.

共引文献95

同被引文献384

引证文献40

二级引证文献325

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部